EUVIMEDEUVIMED entdecken
Crossref

Zhimu-Huangbai herb-pair ameliorates hepatic steatosis in mice by regulating IRE1α/XBP1s pathway to inhibit SREBP-1c

Wenjun Zhao, Xiaoying Wang, Wenlong Nie, Min Jiang, Yuan Zhao, Tong Zhang, Yue Ding

Phytomedicine · 2024

DOI: 10.1016/j.phymed.2024.156017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024. Verfasst von Wenjun Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Endoplasmic Reticulum Stress, Endoribonucleases, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Shanghai Education Development Foundation, Program of Shanghai Academic Research Leader.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Currently, there is a lack of validated pharmacological interventions for non-alcoholic fatty liver disease (NAFLD), which is characterized by the accumulation of hepatic triglyceride. Zhimu-Huangbai (ZH) herb-pair is a traditional Chinese medicine that regulates glucose and lipid metabolism disorders. However, the precise mechanisms underlying the preventive effects of hepatic triglyceride induced by high-fat diet (HFD) remain elusive. PURPOSE: The study aimed to examine the impact of ZH herb-pair on NAFLD in mice and explore the underlying mechanisms, particularly its effects on endoplasmic reticulum (ER) stress and lipid metabolism. METHODS: NAFLD was induced in mice using HFD, and the treated mice were orally administered ZH, metformin (Glucophage) or lovastatin. The lipid metabolism factors, ER stress markers, and the unfolded protein response (UPR) branch factors were measured using immunohistochemistry, western blotting or qRT-PCR. Co-Immunoprecipitation (CoIP) was performed to reveal the connection between SCAP and SREBP-1c. Tunicamycin (TM) and plasmid delivery were used to induce acute ER stress or crease XBP1 gain function models. The main compounds in ZH binding to IRE1α protein were studied by molecular docking and cellular thermal shift assay (CETSA). RESULTS: Treatment with ZH significantly ameliorated hepatic steatosis and reduced lipid synthesis process mainly inhibiting the expression of mature active form of SREBP-1c through relieving ER stress. The expression of IRE1α and XBP1s was inhibited after treatment with ZH. In addition, ZH improved the fatty liver phenotype caused by XBP1 overexpression via decreasing srebp1c transcription. In vitro experimental results suggested that the main compounds in ZH decreased cellular TG contents. Mechanistically, ZH targeted IRE1α and inhibited XBP1s mRNA expression to relieve ER stress and inhibit SREBP-1c production. CONCLUSIONS: ZH herb-pair can protect against NAFLD by reducing the expression of SREBP-1c, in part, via regulating IRE1α/XBP1s pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalEndoplasmic Reticulum StressEndoribonucleasesNon-alcoholic Fatty Liver DiseaseProtein Serine-Threonine KinasesAnimalsHumansMaleMiceDiet, High-FatLipid MetabolismLiverLovastatinMetforminMice, Inbred C57BLSignal TransductionSterol Regulatory Element Binding Protein 1TriglyceridesUnfolded Protein ResponseX-Box Binding Protein 1

Stichwörter der Autor:innen

Endoplasmic reticulum stressIRE1α/XBP1s pathwayNon-alcoholic fatty liver diseaseSREBP-1cZhimu-Huangbai herb-pairs

Substanzen

Drugs, Chinese HerbalEndoribonucleasesErn1 protein, mouseLovastatinMetforminProtein Serine-Threonine KinasesSrebf1 protein, mouseSterol Regulatory Element Binding Protein 1TriglyceridesX-Box Binding Protein 1

Autor:innen und Institutionen

  • School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China.
  • Experiment Center for Science and Technology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China.
  • School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China. Electronic address: zhangtongshutcm@hotmail.com.
  • School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China; National Innovation Platform for Medical Industry-education Integration, Shanghai University of Traditional Chinese Med…

Förderung

  • Shanghai Education Development Foundation
  • Program of Shanghai Academic Research Leader

Zitieren

APA

Zhao, W., Wang, X., Nie, W., Jiang, M., Zhao, Y., Zhang, T., & Ding, Y. (2024). Zhimu-Huangbai herb-pair ameliorates hepatic steatosis in mice by regulating IRE1α/XBP1s pathway to inhibit SREBP-1c. Phytomedicine. https://doi.org/10.1016/j.phymed.2024.156017

Vancouver

Zhao W, Wang X, Nie W, Jiang M, Zhao Y, Zhang T, et al. Zhimu-Huangbai herb-pair ameliorates hepatic steatosis in mice by regulating IRE1α/XBP1s pathway to inhibit SREBP-1c. Phytomedicine. 2024. doi:10.1016/j.phymed.2024.156017

BibTeX
@article{Zhao2024,
  author = {Zhao, Wenjun and Wang, Xiaoying and Nie, Wenlong and Jiang, Min and Zhao, Yuan and Zhang, Tong and Ding, Yue},
  title = {Zhimu-Huangbai herb-pair ameliorates hepatic steatosis in mice by regulating IRE1α/XBP1s pathway to inhibit SREBP-1c},
  journal = {Phytomedicine},
  year = {2024},
  doi = {10.1016/j.phymed.2024.156017}
}
Kostenlos starten →